Genetic background of arterial hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010804

Enrollment

300

Registered

2016-07-11

Start date

2016-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I10.0

Interventions

Group 1: Patients with therapy resistant hypertension Intervention: genotyping of DNA from blood sample.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with therapy resistant hypertension.

Exclusion criteria

Exclusion criteria: Age < 18 yrs. Secondary causes of hypertension, pseudohypertension.

Design outcomes

Primary

Measure	Time frame
Prevalence of known genetic variants of hypertension.	—

Secondary

Measure	Time frame
Genotypes of risk variants Genepanel analysis Exome (WES)- or genomesequencing (WGS)	—

Countries

Germany

Contacts

Public ContactHannes Reuter

Universitäres Hypertoniezentrum Köln

hannes.reuter@uk-koeln.de0221 47832401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026